Oregon Public Employees Retirement Fund increased its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 32.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 267,763 shares of the company’s stock after buying an additional 65,146 shares during the period. Procter & Gamble accounts for about 0.5% of Oregon Public Employees Retirement Fund’s portfolio, making the stock its 25th biggest position. Oregon Public Employees Retirement Fund’s holdings in Procter & Gamble were worth $41,142,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of PG. Vanguard Group Inc. raised its position in shares of Procter & Gamble by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock worth $37,155,222,000 after purchasing an additional 3,189,111 shares during the last quarter. Kingstone Capital Partners Texas LLC raised its stake in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Procter & Gamble by 1.8% in the 2nd quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock valued at $9,439,341,000 after purchasing an additional 1,060,713 shares during the last quarter. Norges Bank purchased a new stake in Procter & Gamble during the 2nd quarter worth about $5,099,644,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Procter & Gamble by 1.7% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 17,385,571 shares of the company’s stock worth $2,770,035,000 after buying an additional 294,673 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares in the company, valued at approximately $146,429.03. The trade was a 42.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.20% of the stock is currently owned by corporate insiders.
Procter & Gamble News Roundup
- Positive Sentiment: P&G’s pricing power and margin resilience are highlighted in sector write-ups that include PG as a defensive name, supporting upside and dividend reliability. 5 Under-the-Radar Consumer Staples Stocks With Pricing Power (PG)
- Positive Sentiment: Analyst and commentary pieces note operational focus under new leadership (pricing, cost discipline) that could drive margin improvement over time. Procter & Gamble: Intense Focus Makes It Attractive
- Neutral Sentiment: P&G agreed to change Crest kids’ toothpaste packaging and marketing after the Texas AG raised concerns — the move removes regulatory uncertainty but adds short-term remediation and reputational work. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Neutral Sentiment: Coverage highlighting legal scrutiny alongside a new CEO focus on pricing frames a mixed narrative — potential for better pricing execution balanced against regulatory/legal headline risk. Should Legal Scrutiny And New CEO Focus On Pricing Shape Procter & Gamble’s (PG) Investment Narrative?
- Neutral Sentiment: Wells Fargo trimmed its price target (keeps Overweight), reflecting model resets across categories but maintaining a constructive stance — suggests upside remains but at lower conviction. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
- Neutral Sentiment: TD Cowen (reported via market outlets) and other shops have lowered targets — analysts still often keep Buy/Overweight ratings, but trimmed targets compress near-term upside. Benzinga (TD Cowen target note)
- Negative Sentiment: Valuation-focused pieces argue PG trades above intrinsic value after recent gains; some analysts call it a Hold given modest topline growth outlook versus ~20x+ multiples. Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
- Negative Sentiment: The stock recently hit a 52-week low amid softer category demand and promotional pressure, signaling macro weakness in core markets that could weigh near-term results. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?
- Negative Sentiment: Broker notes and headlines show growing short-term caution (extended losing sessions, peers upgraded while PG is watched), leaving the stock sensitive to execution and macro updates. Procter & Gamble extends losing streak for seventh straight session
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating for the company in a report on Thursday, December 18th. Morgan Stanley set a $175.00 target price on Procter & Gamble in a research note on Monday, October 27th. Piper Sandler began coverage on Procter & Gamble in a report on Wednesday. They issued a “neutral” rating and a $150.00 price target for the company. Raymond James Financial cut their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Finally, UBS Group lowered their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Fifteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $169.23.
Read Our Latest Stock Report on Procter & Gamble
Procter & Gamble Trading Up 2.6%
PG opened at $141.57 on Friday. The stock has a market capitalization of $330.81 billion, a PE ratio of 20.67, a P/E/G ratio of 4.65 and a beta of 0.39. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The firm’s fifty day moving average price is $145.11 and its 200 day moving average price is $151.70.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter last year, the business posted $1.93 EPS. Procter & Gamble’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were given a $1.0568 dividend. The ex-dividend date was Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is 61.75%.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
